Medtronic Begins Active Portfolio Management Phase

Medtronic reported FY 3Q22 orthopedic sales of $793 million, +7.1% vs. FY 3Q21. Broad-based omicron-related absenteeism peaked in mid-January, and company leadership said that trends improved in February. However, healthcare worker shortages are expected to remain a pressure throughout the year.

The company anticipates that China could...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us